Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-21

Study Completion Date

2020-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive behavioral therapy for insomnia (CBT-I) has been the 'gold standard' for the treatment of insomnia. There is a need to increase access to treatment, particularly for patients in more rural locations where providers may be scarce. One solution is to utilize telemedicine which is "the use of electronic communications to provide and support health care when distance separates the provider from the patient." So the purpose of the study is to determine if receiving CBT-I by video teleconferencing works just as well as in-person treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Behavioral Therapy for Insomnia: Face-to-Face Versus Telemedicine

NCT03293745

Insomnia

COMPLETED NA

Non-inferiority Study of Telemedicine Versus Conventional CBT-I in Recently Hospitalized Patients With Insomnia

NCT03267537

Insomnia

UNKNOWN NA

Effectiveness of Internet Cognitive Behavioral Therapy Intervention for Treating Insomnia

NCT00328250

Sleep Initiation and Maintenance Disorders

COMPLETED PHASE1/PHASE2

Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia

NCT01549899

Insomnia

COMPLETED PHASE3

Online or Face-to-face Treatment for Insomnia?

NCT01955850

Insomnia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insomnia Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT-I in person

Group Type ACTIVE_COMPARATOR

CBT-I in person

Intervention Type BEHAVIORAL

6 weeks of CBT-I in person, one 1-hour long session per week

CBT-I via telemedicine

Group Type EXPERIMENTAL

CBT-I via Telemedicine

Intervention Type BEHAVIORAL

6 weeks of CBT-I via telemedicine, one 1-hour long session per week

Waitlist Control

Patients in this arm will receive in person CBT-I treatment after conclusion of the study.

Group Type OTHER

No intervention

Intervention Type OTHER

Patients in this arm will receive no intervention but will receive CBT-I treatment after conclusion of the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CBT-I in person

6 weeks of CBT-I in person, one 1-hour long session per week

Intervention Type BEHAVIORAL

CBT-I via Telemedicine

6 weeks of CBT-I via telemedicine, one 1-hour long session per week

Intervention Type BEHAVIORAL

No intervention

Patients in this arm will receive no intervention but will receive CBT-I treatment after conclusion of the study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet current DSM5 criteria for Insomnia Disorder as determined by clinician interview
* ISI score greater than 14, with self-reported duration of insomnia of at least 3 months
* Ability to read and speak English
* Own a personal computer with an internet connection sufficient to utilize the SleepTM and REDCap platform
* BMI less than 30
* Between the ages of 21-50

Exclusion Criteria

* Unable or unwilling to provide informed consent
* Individuals with an untreated sleep disorder other than insomnia (Individuals with sleep apnea who are adherent with CPAP treatment (average 4 hours use per night) will be eligible to participate)
* A clinically unstable medical condition as defined by a new diagnosis or change in medical management in the previous 2 months
* Individuals with substance abuse/dependence, bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia, and other psychotic disorders
* Individuals with prominent current suicidal or homicidal ideation
* Unable to perform tests due to inability to communicate verbally, inability to read and write; less than a 5th grade reading level; visual, hearing, or cognitive impairment
* Any use of medications or OTC products that might impact sleep or metabolism

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No